Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LUMRYZ
- Development stage
- Approved
- Lead developer
- Avadel Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
LUMRYZ (sodium oxybate) is an extended-release oral suspension developed by Avadel Pharmaceuticals for the treatment of sleep disorders. As a GABAB receptor agonist and central nervous system depressant, it is designed to provide a full night's therapeutic effect with a single bedtime dose, distinguishing it from immediate-release oxybate products that require a second middle-of-the-night dose. While currently FDA-approved for excessive daytime sleepiness and cataplexy in adults with narcolepsy, LUMRYZ is being evaluated in the Phase 3 REVITALYZ trial for idiopathic hypersomnia, a condition characterized by chronic excessive daytime sleepiness despite long or normal sleep times.
- Brand names
- LUMRYZ
- Other names
- sodium oxybate extended-releaseonce-nightly sodium oxybate
02
Targets
GABA-B (Gamma-aminobutyric acid receptor type B)Gamma-hydroxybutyrate receptor
Beyond the preview
Go deeper on LUMRYZ.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LUMRYZ.